In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani
Open Access
Abstract
Flavonolignans from the seeds of the milk thistle (Silybum marianum) have been extensively used in folk medicine for centuries. Confirmation of their properties as hepatoprotective, antioxidant and anticancer has been obtained using standardized extracts and purified flavonolignans. Information on their potential effect on Leishmania is very scarce. We have investigated the effect of silymarin, silybin and related flavonolignans on the multiplication of promastigotes in vitro and ex vivo on intracellular amastigotes of L. infantum (Li) and L. donovani (Ld), causative agents of human and canine visceral leishmaniasis (VL). In addition, the potential synergistic effect of the most active molecule and well-established antileishmanial drugs against promastigotes was explored. Dehydroisosilybin A elicited the highest inhibition against Ld and Li promastigotes with an approximate IC50 of 90.23 µM. This molecule showed a moderate synergism with amphotericin B (AmB) but not with SbIII or paromomycin, although it was ineffective against amastigotes. Antileishmanial activity on intracellular amastigotes of the two diastereoisomers of dehydrosilybin (10 µM) was comparable to that elicited by 0.1 µM AmB. Antiproliferative activity and safety of flavonolignans suggest the interest of exploring their potential value in combination therapy against VL.Keywords
Funding Information
- Czech Science Foundation 18-00150S (18-00150S)
- MEYS LTC (17009)
- NMTrypI – New Medicines for Trypanosomatidic Infections (grant agreement nº 603240)
- European Cooperation in Science and Technology (Action CM1307)
This publication has 39 references indexed in Scilit:
- A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific HitPLOS Neglected Tropical Diseases, 2011
- Identification of hepatoprotective flavonolignans from silymarinProceedings of the National Academy of Sciences, 2010
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific DifferencesAntimicrobial Agents and Chemotherapy, 2009
- Risk-communication capability for public health emergencies varies by community diversityBMC Research Notes, 2008
- Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasiteBMC Research Notes, 2008
- Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle ExtractDrug Metabolism and Disposition, 2008
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- High-Affinity Binding of Silybin Derivatives to the Nucleotide-Binding Domain of a Leishmania tropica P-Glycoprotein-Like Transporter and Chemosensitization of a Multidrug-Resistant Parasite to DaunomycinAntimicrobial Agents and Chemotherapy, 2001
- Leishmania infantum: Infection of macrophages in vitro with promastigotesInternational Journal for Parasitology, 1996